More Magnificent Seven earnings are coming next week, helping to decide the direction of a stock market that’s becoming more discerning, while the latest data on…
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | ReutersThe…
Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after markets closed on Tuesday. The US…
U.S. President Donald Trump delivers remarks at the Business Roundtable’s quarterly meeting at the Business Roundtable headquarters on March 11, 2025 in Washington, DC. Andrew Harnik |…
Our president, Donald Trump , tells us that “what we are doing is big,” so there might be economic consequences to come that we don’t like.…
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo,…
My top 10 things to watch Tuesday, Nov. 26 1. The outgoing Biden administration proposed a rule that would expand access to obesity drugs for millions…
Investors want to know whether Eli Lilly is seeing the same pricing pressures on its blockbuster weight loss drug Zepbound that Novo Nordisk experienced with its…
A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs.Roundhill Investments’ GLP-1 & Weight Loss ETF (OZEM), which began trading…
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. U.S.…